MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


AstraZeneca Covid-19 vaccine wins approval in UK

StockMarketWire.com

Drugmaker AstraZeneca said its COVID-19 vaccine had been approved for emergency supply in the UK, with the first doses set to be released on Tuesday, allowing vaccinations to begin early in the new year.

The UK Medicines and Healthcare products Regulatory Agency had provided authorisation for emergency supply of COVID-19 vaccine AstraZeneca, formerly AZD1222, for the active immunisation of individuals 18 years or older.

The authorisation recommended two doses administered with an interval of between four and 12 weeks.





At 8:33am: (LON:AZN) Astrazeneca PLC share price was 0p at 8633p



Story provided by StockMarketWire.com